Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis
Year: 2022
Type: review
Study designs: Systematic Review, Meta-Analysis
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Defense, Ministry of Health -Singapore, National Medical Research Council, National Institute on Alcohol Abuse and Alcoholism, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences, National Center for Advancing Translational Sciences, DOD Peer Reviewed Cancer Research Program
Awards: G1140353899, G1198267417, G1316440902, G1370780335, G1494183008, G1622551803, G1820179381, G1893910623, G2323685147, G2928778974, G4119534169, Novel IL-23 inhibitor for the treatment of alcohol associated liver disease, ABBREVIATED MAGNETIC RESONANCE IMAGING AND BIOMARKER-BASED DETECTION OF EARLY LIVER CANCER, G7198334374, G745677937, G7501542120, G7562742651, G8150884884, G8166743225, San Diego Digestive Diseases Research Center, San Diego Cirrhosis Clinical Research Network
OpenAlex ID: W4289941801
